Catalog Number 04827031190 |
Device Problem
Incorrect Or Inadequate Test Results (2456)
|
Patient Problem
No Known Impact Or Consequence To Patient (2692)
|
Event Date 02/09/2015 |
Event Type
malfunction
|
Manufacturer Narrative
|
A sample from the patient was investigated and the customer's results were confirmed.The patient was injected with xolair (omalizumab, anti-human ige antibody, novartis) for "rush oral immunotherapy.".
|
|
Manufacturer Narrative
|
As part of the investigation, xolair was added to human ige samples and the results compared with a drug free control sample.The spiked samples showed reduced recovery of ige.A pharmacological interference with the assay was confirmed.
|
|
Manufacturer Narrative
|
Additional information was provided concerning the patient.The patient's height was (b)(6).The patient was taking 300 mg/day of xolair once every two weeks from (b)(6) 2014 through current day.
|
|
Event Description
|
The customer received questionable immunoglobulin (ige) results for one patient sample from an unknown roche analyzer.Original first result was 1701.0 iu/ml, repeat result was 1799.0 iu/ml.Auto dilution 1:5 result was 938.4 iu/ml (calculated 4692.0 iu/ml).Auto dilution 1:10 result was 509.8 iu/ml (calculated 5098.0 iu/ml).Manual dilution 1:50 result was 113.8 iu/ml (calculated 5690 iu/ml).Information concerning which result was reported outside the laboratory or if the patient was adversely affected was requested, but was not provided.
|
|
Manufacturer Narrative
|
This event occurred in (b)(6).
|
|
Search Alerts/Recalls
|